CISPLATIN, ETOPOSIDE, AND IFOSFAMIDE SALVAGE THERAPY FOR REFRACTORY OR RELAPSING GERM-CELL CARCINOMA

被引：90
作者：
HARSTRICK, A
SCHMOLL, HJ
WILKE, H
KOHNEWOMPNER, CH
STAHL, M
SCHOBER, C
CASPER, J
BRUDEREK, L
SCHMOLL, E
BOKEMEYER, C
BERGMANN, L
LAMMERS, U
FREUND, M
POLIWODA, H
机构：
[1] UNIV FRANKFURT, DEPT HEMATOL & ONCOL, W-6000 FRANKFURT 1, GERMANY
[2] UNIV MUNSTER, DEPT HEMATOL & ONCOL, W-4400 MUNSTER, GERMANY
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1991年 / 9卷 / 09期
关键词：
D O I：
10.1200/JCO.1991.9.9.1549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1549 / 1555
页数：7
相关论文
共 23 条
[1]   PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS [J].
BIRCH, R ;
WILLIAMS, S ;
CONE, A ;
EINHORN, L ;
ROARK, P ;
TURNER, S ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :400-407
[2]   ROLE OF ETOPOSIDE-BASED CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING GERM-CELL TUMORS [J].
BOSL, GJ ;
YAGODA, A ;
GOLBEY, RB ;
WHITMORE, W ;
HERR, H ;
SOGANI, P ;
MORSE, M ;
VOGELZANG, N ;
MACDONALD, G .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) :423-428
[3]   ETOPOSIDE AND ETOPOSIDE IFOSFAMIDE THERAPY FOR REFRACTORY TESTICULAR-TUMORS [J].
BREMER, K ;
NIEDERLE, N ;
KRISCHKE, W ;
HIGI, M ;
SCHEULEN, ME ;
SCHMIDT, CG ;
SEEBER, S .
CANCER TREATMENT REVIEWS, 1982, 9 :79-84
[4]   A PHASE-II STUDY OF ORAL VP-16-213 IN NON-SEMINOMATOUS TESTICULAR CANCER [J].
CAVALLI, F ;
KLEPP, O ;
RENARD, J ;
ROHRT, M ;
ALBERTO, P .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (02) :245-249
[5]  
COOPER K, 1989, P AN M AM SOC CLIN, V8, P144
[6]   EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL [J].
EINHORN, LH ;
WILLIAMS, SD ;
LOEHRER, PJ ;
BIRCH, R ;
DRASGA, R ;
OMURA, G ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :387-391
[7]   VP16-213 AS A SINGLE AGENT IN ADVANCED TESTICULAR-TUMORS [J].
FITZHARRIS, BM ;
KAYE, SB ;
SAVERYMUTTU, S ;
NEWLANDS, ES ;
BARRETT, A ;
PECKHAM, MJ ;
MCELWAIN, TJ .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (09) :1193-1197
[8]  
GHOSN M, 1988, CANCER, V62, P24, DOI 10.1002/1097-0142(19880701)62:1<24::AID-CNCR2820620106>3.0.CO
[9]  
2-Y
[10]   SUCCESSFUL TREATMENT OF RESISTANT GERMINAL NEOPLASMS WITH VP-16 AND CISPLATIN - RESULTS OF A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J].
HAINSWORTH, JD ;
WILLIAMS, SD ;
EINHORN, LH ;
BIRCH, R ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) :666-671
123